US30233G2093 - Common Stock
EYEPOINT PHARMACEUTICALS INC
NASDAQ:EYPT (5/17/2024, 7:00:02 PM)
After market: 11.84 0 (0%)11.84
-0.68 (-5.43%)
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. The company is headquartered in Watertown, Massachusetts and currently employs 144 full-time employees. The company went IPO on 2005-01-27. The firm is focused on the business of developing and commercializing ophthalmic products for the treatment of eye diseases. The firm's pipeline leverages its Durasert technology (Durasert) for sustained intraocular drug delivery, including delivery of EYP-1901, an investigational sustained delivery intravitreal treatment in Phase II clinical trials. The Company’s commercial product, YUTIQ, is a once-every-three-year treatment for chronic non-infectious uveitis affecting the posterior segment of the eye that utilizes a non-erodible formulation of Durasert. Its commercial product also includes DEXYCU, which is administered as a single dose directly into the surgical site at the end of ocular surgery and is a long-acting intraocular product for the treatment of post-operative inflammation. Its other products include ILUVIEN, Retisert, and Vitrasert.
EYEPOINT PHARMACEUTICALS INC
480 Pleasant St Ste B300
Watertown MASSACHUSETTS 02472
P: 16179265000
CEO: Nancy Lurker
Employees: 144
Website: https://eyepointpharma.com/
WATERTOWN, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing...
EYPT stock results show that EyePoint Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips EyePoint Pharmaceuticals (NASDAQ:EYPT) just reported results for the first quar...
– Company on track to initiate the Phase 3 LUGANO pivotal non-inferiority trial of DURAVYU™ in wet AMD in 2H 2024 – – $299 million of cash and investments...
Which stocks are moving on Monday?
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Here you can normally see the latest stock twits on EYPT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: